Basic Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Jul 7, 2018; 24(25): 2710-2721
Published online Jul 7, 2018. doi: 10.3748/wjg.v24.i25.2710
Table 1 Intra-individual comparison of induced tumor necrosis (%) between primary hepatocellular carcinomas and intrahepatically implanted R1 rhabdomyosarcomas in combretastatin-A4-phosphate-treated group
RatPrimary HCC
Implanted hepatic R1
Tumor codeCA4P-induced necrosis, %Tumor diameter in mmTumor vascularity1Tumor differentiation2Tumor codeCA4P-induced necrosis, %Tumor diameter in mmTumor vascularity1
1HCC_121.89.7++IIR1_172.312.1++
HCC_216.46.5++III-IV
HCC_3010.9++III
2HCC_443.16.4+IIIR1_284.512.6++
HCC_523.38.5++III
3HCC_692.38.1+I-IIR1_399.210++
HCC_796.56.2+II
HCC_819.810+I
HCC_998.910+II
4HCC_1099.214.3+I-IIR1_496.89.8++
5HCC_1127.618.3+IIIR1_599.48.3++
HCC_124.97.8++II-III
HCC_1362.713+I-II
6HCC_1447.614.2+, +++3I, III4R1_697.79++
HCC_1546.414.2+, +++3I, III4
7HCC_1676.112.5+II-IIIR1_798.36.2++
HCC_17552.611.9+III
HCC_1833.410.4+III
HCC_1991.29+I-II
Mean ± SD50.2 ± 1.810.6 ± 0.2//92.6 ± 1.59.7 ± 0.3/